Jul 6, 2015Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome
Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to...
- May 28, 2015
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast: What: Akcea Therapeutics Webcast When: Thursday, June 4 at 1:00 p.m. ET / 10:00 a.m. PT Where: www.isispharm.com How:...
- Jun 24, 2013Include multimedia assets in your release for better visibility
Educating your customers and prospects by sharing expertise and insight is at the heart of content marketing. According to a recent article by Joe Pulizzi,...
Mar 1, 2011Use This To Test Potential Limitations With Your Site Design
ACME Inc. (NYSE: ) today reported financial results for the fourth quarter and full year ended December 31, 2010. For the fourth quarter 2010, we...
Nov 6, 2007Subheadline 1
Body copy of news release